BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Peach buds may be far less dormant than scientists once believed. This study shows that vegetative buds in peach do not simply shut down during ...
A research team has uncovered the genomic basis behind why some vine tea varieties accumulate far more dihydromyricetin than others.
Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
A research team found that hybrid maize (Zea mays) is often harvested with high seed moisture, increasing drying costs and ...
Using multi-year field trials and transcriptome-wide allele-specific expression analyses, they showed maternal inbred choice can speed seed ...
The sequence Met-Glu-His-Phe-Pro-Gly-Pro gives Semax its hybrid nature: the ACTH fragment portion is thought to influence melanocortin-related signaling, while the PGP motif appears to impart ...
Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, April 8, 2026 ...
Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the Caris Precision Oncology Alliance ® (Caris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results